Alnylam Pharmaceuticals Inc (ALNY) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ALNY.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 18 | $235 | $90 | $174.72 | $150.46 | 16.12% |
The Trend in the Analyst Price Target
Over the past 154 days, ALNY's average price target has gone up $10.76.
ALNY reports an average of 17.68% for its upside potential over the past 52 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-06-05 | 18 | 235 | 90 | 174.72 | 145.60 | 20% |
| 2021-05-22 | 18 | 235 | 90 | 174.72 | 140.06 | 24.75% |
| 2021-05-15 | 18 | 235 | 90 | 174.72 | 135.70 | 28.75% |
| 2021-05-08 | 18 | 235 | 90 | 174.89 | 131.30 | 33.2% |
| 2021-04-25 | 19 | 235 | 90 | 175.11 | 136.72 | 28.08% |
| 2021-04-17 | 19 | 235 | 88 | 175.00 | 138.88 | 26.01% |
| 2021-04-10 | 20 | 235 | 88 | 175.25 | 138.23 | 26.78% |
| 2021-04-03 | 20 | 235 | 88 | 175.25 | 141.81 | 23.58% |
| 2021-03-20 | 21 | 235 | 88 | 174.62 | 144.16 | 21.13% |
| 2021-03-13 | 22 | 235 | 88 | 174.64 | 142.20 | 22.81% |
| 2021-03-06 | 22 | 235 | 88 | 174.64 | 143.39 | 21.79% |
| 2021-02-27 | 22 | 235 | 88 | 174.09 | 148.10 | 17.55% |
| 2021-02-20 | 22 | 235 | 88 | 174.41 | 155.06 | 12.48% |
| 2021-02-13 | 23 | 235 | 88 | 172.78 | 157.92 | 9.41% |
| 2021-02-06 | 23 | 225 | 90 | 167.00 | 165.11 | 1.14% |
| 2021-01-30 | 23 | 225 | 90 | 166.00 | 150.48 | 10.31% |
| 2021-01-23 | 23 | 225 | 90 | 166.00 | 172.38 | -3.7% |
| 2021-01-16 | 23 | 225 | 90 | 166.00 | 166.36 | -0.22% |
| 2021-01-09 | 23 | 225 | 90 | 164.13 | 146.66 | 11.91% |
| 2021-01-02 | 23 | 225 | 90 | 163.96 | 129.97 | 26.15% |
| 2020-12-26 | 23 | 225 | 90 | 163.96 | 137.56 | 19.19% |
| 2020-12-19 | 23 | 225 | 93 | 164.13 | 142.39 | 15.27% |
| 2020-12-09 | 23 | 225 | 93 | 163.61 | 124.04 | 31.9% |
| 2020-12-07 | 23 | 225 | 93 | 163.61 | 126.81 | 29.02% |
| 2020-11-28 | 23 | 225 | 93 | 163.61 | 129.86 | 25.99% |
| 2020-11-05 | 23 | 225 | 90 | 163.43 | 137.86 | 18.55% |
| 2020-10-24 | 23 | 225 | 90 | 163.74 | 131.84 | 24.2% |
| 2020-09-30 | 23 | 225 | 90 | 163.78 | 145.60 | 12.49% |
| 2020-09-07 | 22 | 225 | 90 | 164.64 | 122.83 | 34.04% |
| 2020-08-21 | 21 | 225 | 90 | 164.38 | 136.60 | 20.34% |
| 2020-08-10 | 20 | 202 | 90 | 161.40 | 138.57 | 16.48% |
| 2020-08-06 | 20 | 202 | 90 | 161.15 | 144.12 | 11.82% |
| 2020-07-20 | 20 | 202 | 89 | 159.60 | 165.49 | -3.56% |
| 2020-07-14 | 20 | 202 | 89 | 158.45 | 157.23 | 0.78% |
| 2020-06-27 | 21 | 202 | 74 | 152.57 | 151.90 | 0.44% |
| 2020-06-05 | 21 | 202 | 74 | 152.00 | NA | NA% |
ALNY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.64 | 3 | 9 | 9 | 0 | 0 | 21 |
The Trend in the Broker Recommendations
Over the past 30 weeks, ALNY's average broker recommendation rating worsened by 0.62.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Alnylam Pharmaceuticals Inc's average analyst price target is greater than 92.64% of all US stocks.
- The number of analysts covering the stock of ALNY is greater than 95.97% of Pharmaceutical Products stocks.
- ALNY has a less variance in analysts' estimates than 8.23% of all US stocks.
- ALNY has a higher upside potential (average analyst target price relative to current price) than 14.84% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Alnylam Pharmaceuticals Inc are LLY, SGEN and SRPT.
Is ALNY a Buy, Hold or Sell? See the POWR Ratings now!